<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T16:17:33Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/6892" metadataPrefix="edm">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/6892</identifier><datestamp>2025-03-03T10:15:48Z</datestamp><setSpec>com_10324_1134</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1213</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xsi:schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd">
<edm:ProvidedCHO rdf:about="http://uvadoc.uva.es/handle/10324/6892">
<dc:creator>Davidsen, Peter K.</dc:creator>
<dc:creator>Herbert, Jhon M.</dc:creator>
<dc:creator>Antczak, Kim</dc:creator>
<dc:creator>Ferrer, Elisabet</dc:creator>
<dc:creator>Peinado, Víctor I.</dc:creator>
<dc:creator>González Martínez, Constancio</dc:creator>
<dc:creator>Roca, Josep</dc:creator>
<dc:creator>Egginton, Stuart</dc:creator>
<dc:creator>Barberá, Joan A.</dc:creator>
<dc:creator>Falciani, Francesco</dc:creator>
<dc:date>2014</dc:date>
<dc:description>Producción Científica</dc:description>
<dc:description>Background: A relatively large percentage of patients with chronic obstructive pulmonary disease (COPD) develop&#xd;
systemic co-morbidities that affect prognosis, among which muscle wasting is particularly debilitating. Despite&#xd;
significant research effort, the pathophysiology of this important extrapulmonary manifestation is still unclear. A key&#xd;
question that remains unanswered is to what extent systemic inflammatory mediators might play a role in this&#xd;
pathology.&#xd;
Cigarette smoke (CS) is the main risk factor for developing COPD and therefore animal models chronically exposed&#xd;
to CS have been proposed for mechanistic studies and biomarker discovery. Although mice have been successfully&#xd;
used as a pre-clinical in vivo model to study the pulmonary effects of acute and chronic CS exposure, data suggest&#xd;
that they may be inadequate models for studying the effects of CS on peripheral muscle function. In contrast,&#xd;
recent findings indicate that the guinea pig model (Cavia porcellus) may better mimic muscle wasting.&#xd;
Methods: We have used a systems biology approach to compare the transcriptional profile of hindlimb skeletal&#xd;
muscles from a Guinea pig rodent model exposed to CS and/or chronic hypoxia to COPD patients with muscle&#xd;
wasting.&#xd;
Results: We show that guinea pigs exposed to long-term CS accurately reflect most of the transcriptional changes&#xd;
observed in dysfunctional limb muscle of severe COPD patients when compared to matched controls. Using network&#xd;
inference, we could then show that the expression profile in whole lung of genes encoding for soluble inflammatory&#xd;
mediators is informative of the molecular state of skeletal muscles in the guinea pig smoking model. Finally, we show&#xd;
that CXCL10 and CXCL9, two of the candidate systemic cytokines identified using this pre-clinical model, are indeed&#xd;
detected at significantly higher levels in serum of COPD patients, and that their serum protein level is inversely&#xd;
correlated with the expression of aerobic energy metabolism genes in skeletal muscle.&#xd;
Conclusions: We conclude that CXCL10 and CXCL9 are promising candidate inflammatory signals linked to the&#xd;
regulation of central metabolism genes in skeletal muscles. On a methodological level, our work also shows that a&#xd;
system level analysis of animal models of diseases can be very effective to generate clinically relevant hypothesis.</dc:description>
<dc:format>application/pdf</dc:format>
<dc:identifier>http://uvadoc.uva.es/handle/10324/6892</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>BioMed Central</dc:publisher>
<dc:subject>EPOC</dc:subject>
<dc:title>A systems biology approach reveals a link between systemic cytokines and skeletal muscle energy metabolism in a rodent smoking model and human COPD</dc:title>
<dc:type>info:eu-repo/semantics/article</dc:type>
<edm:type>TEXT</edm:type>
</edm:ProvidedCHO>
<ore:Aggregation rdf:about="http://uvadoc.uva.es/handle/10324/6892#aggregation">
<edm:aggregatedCHO rdf:resource="http://uvadoc.uva.es/handle/10324/6892"/>
<edm:dataProvider>UVaDOC. Repositorio Documental de la Universidad de Valladolid</edm:dataProvider>
<edm:isShownAt rdf:resource="http://uvadoc.uva.es/handle/10324/6892"/>
<edm:isShownBy rdf:resource="https://uvadoc.uva.es/bitstream/10324/6892/1/Constancio%2019.pdf"/>
<edm:provider>Hispana</edm:provider>
<edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/4.0/"/>
</ore:Aggregation>
<edm:WebResource rdf:about="https://uvadoc.uva.es/bitstream/10324/6892/1/Constancio%2019.pdf">
<edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/4.0/"/>
</edm:WebResource>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>